TRUIST FINANCIAL CORP - KAZIA THERAPEUTICS LTD ownership

KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 19 filers reported holding KAZIA THERAPEUTICS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TRUIST FINANCIAL CORP ownership history of KAZIA THERAPEUTICS LTD
ValueSharesWeighting
Q4 2021$264,000
-19.8%
31,420
+8.3%
0.00%
-100.0%
Q3 2021$329,000
+14.6%
29,0200.0%0.00%
Q2 2021$287,000
-17.3%
29,020
+3.6%
0.00%
-100.0%
Q1 2021$347,000
+14.1%
28,020
-20.5%
0.00%0.0%
Q4 2020$304,000
-30.3%
35,260
-45.4%
0.00%0.0%
Q3 2020$436,00064,5900.00%
Other shareholders
KAZIA THERAPEUTICS LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Transform Wealth, LLC 106,245$35,0000.01%
UBS Group AG 1,546$5,0000.00%
Renaissance Technologies 34,325$115,0000.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
BREWIN DOLPHIN LTD 32$1070.00%
MORGAN STANLEY 63,017$210,0000.00%
AdvisorNet Financial, Inc 5$00.00%
View complete list of KAZIA THERAPEUTICS LTD shareholders